Dentists in Vinton, IA Accepting Medicare
4 Dentists found. Showing 1 - 4
 Dr. Alan Stanley Woodhouse, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 207 E 4th Street, Vinton, IA 52349 Phone: 319-472-3282 Fax: 319-472-3282 |
Dr. David W Beecher, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 410 W 4th St, Vinton, IA 52349 Phone: 319-472-3515 Fax: 319-472-3590 |
 Dr. Sara Elizabeth Stuefen, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 207 E 4th St, Vinton, IA 52349 Phone: 319-472-3282 Fax: 319-472-3282 |
Douglas William Hanneman, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 118 East 4th St, Vinton, IA 52349 Phone: 319-472-5209 |
News Archive
KYTHERA Biopharmaceuticals presents its two Phase 2 clinical study results
KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today presented detailed results from two double-blind Phase 2 studies, each designed to evaluate the safety and effectiveness of ATX-101, a first-in-class injectable drug for the reduction of small volumes of fat.
Mass spectroscopy identifies total of 1,210 UCB proteins
Blood tests have been a mainstay of diagnostic medicine since the late 19th century, offering a wealth of information concerning health and disease. Nevertheless, blood derived from the human umbilical cord has yet to be fully mined for its vital health information, according to Rolf Halden, a researcher at Arizona State University's Biodesign Institute.
Ionian Technologies receives supplemental funding from the Gates Foundation
Ionian Technologies, Inc., will continue its efforts to develop a rapid point-of-care diagnostics platform for use in the developing world with supplemental funding from the Bill & Melinda Gates Foundation. This grant from the Foundation will extend the total commitment to this program, which was initiated in November 2008, to $3 million over two years.
Age doesn't matter when considering HCT for patients with MDS, study reveals
Results from a prospective study of 1,280 patients with myelodysplastic syndrome (MDS) showed that survival at 100 days and at two years following hematopoietic cell transplant (HCT) for patients aged 65 and older is comparable to patients aged 55 to 64.
› Verified 2 days ago
Pharmacists
Counselors
Occupational Therapists
Dentists
Clinical Social Workers